Michael S. Huie, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthMichael S. Huie, MD, earned his medical degree from the University of Wisconsin-Madison and completed his residency at UW Hospital and Clinics. He is a member of the UW Health Breast Center.
Specialties
UW Health Clinics
Other Locations
Hospital Affiliation(s)
Meriter Hospital (primary)
University of Wisconsin Hospital and Clinics (secondary)
Languages Spoken
| English |
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
UW School of Medicine and Public Health
| Department of Medicine |
Professional Certifications and Education
| Board Certification |
Internal Medicine
Medical Oncology |
| Fellowship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Residency |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Internship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Medical School |
University of Wisconsin - Madison, 2000
|
Procedures
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
- Bone Marrow Biopsy
- Chemotherapy
- Lumbar Puncture
- Thoracentesis
PubMed Articles
-
Chang JE Peterson C Choi S Eickhoff JC Kim K Yang DT Gilbert LA Rogers ES Werndli JE Huie MS McFarland TA Volk M Blank J Callander NS Longo WL Kahl BS .
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. Br J Haematol. 2011 Oct;155(2):190-7
[PubMed ID: 21848883]
-
Attia S Morgan-Meadows S Holen KD Bailey HH Eickhoff JC Schelman WR Traynor AM Mulkerin DL Campbell TC McFarland TA Huie MS Cleary JF Tevaarwerk AJ Alberti DB Wilding G Liu G .
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies. Cancer Chemother Pharmacol. 2009 Jun;64(1):45-51
[PubMed ID: 18841362]
-
Traynor AM Dubey S Eickhoff JC Kolesar JM Schell K Huie MS Groteluschen DL Marcotte SM Hallahan CM Weeks HR Wilding G Espinoza-Delgado I Schiller JH .
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. J Thorac Oncol. 2009 Apr;4(4):522-6
[PubMed ID: 19347984]
-
Huie M Oettel K Van Ummersen L Kim KM Zhang Y Staab MJ Horvath D Marnocha R Douglas J Drezen A Alberti D Wilding G .
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma. Invest New Drugs. 2006 May;24(3):255-60
[PubMed ID: 16205854]
-
Huie M Carducci M Liu G Wilding G Marnocha R Izquierda M Thomas J .
Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors. Am J Clin Oncol. 2005 Dec;28(6):613-7
[PubMed ID: 16317274]
